Table 1.
Roles of circRNAs in four main immune-related diseases.
Diseases | circRNAs | Functions | Related molecules | Related pathways | Ref |
---|---|---|---|---|---|
Organ-specific autoimmune diseases | |||||
Multiple sclerosis | circ_0005402 | Potential biomarker | —— | —— | (25) |
circ_0035560 | |||||
hsa_circ_0106803 | Potential biomarker | —— | —— | (26) | |
Primary biliary cholangitis | hsa_circ_402458 | Potential biomarker | —— | —— | (27) |
Lupus nephritis | circ_002453 | Potential biomarker | —— | —— | (28) |
Autoimmune myocarditis | circSnx5 | miRNA sponge | miR-544, SOCS1, PU.1 | JAK/STAT signaling pathway, MAPK signaling pathway | (29) |
Systemic autoimmune diseases | |||||
Systemic lupus erythematosus | hsa_circ_0045272 | miRNA sponge | IL-2, hsa-miR-6127 | Apoptosis signaling pathway | (30) |
hsa_circ_0000479 | Potential biomarker | —— | —— | (31) | |
hsa_circ_0044235 | Potential biomarker | —— | —— | (32) | |
hsa_circ_0068367 | |||||
circPTPN22 | Potential activity indicator | —— | —— | (33) | |
hsa_circ_407176 | Potential biomarker | —— | —— | (34) | |
hsa_circ_001308 | |||||
Rheumatoid arthritis | hsa_circ_0001200 | Potential biomarker | —— | —— | (35) |
hsa_circ_0001566 | |||||
hsa_circ_0003972 | |||||
hsa_circ_0008360 | |||||
hsa_circ_0000396 | Potential biomarker | —— | —— | (36) | |
hsa_circ_0130438 | |||||
hsa_circ_0088036 | miRNA sponge | miR-140-3p, SIRT1 | AMPK signaling pathway, mTOR signaling pathway | (37) | |
Primary Sjögren's syndrome | hsa_circ_001264 | Potential biomarker | —— | —— | (38) |
hsa_circ_104121 | |||||
hsa_circ_045355 | |||||
Tumor immunology | |||||
Laryngeal squamous cell carcinoma | hsa_circ_001569 | miRNA sponge | CD274, IL-10, FOXP3 | Th17 cell differentiation | (39) |
hsa_circ_001859 | |||||
Pancreatic adenocarcinoma | circUBAP2 | miRNA sponge | CXCR4, ZEB1 | Wnt signaling pathway, MAPK signaling pathway | (40) |
Melanoma | circ_0020710 | miRNA sponge | miR-370-3p, CXCL12 | mTOR signaling pathway | (41) |
Non-small cell lung cancer | circMET | miRNA sponge | miR-145-5p, CXCL3 | TNF signaling pathway | (42) |
circFGFR1 | miRNA sponge | miR-381-3p, CXCR4 | HIF-1 signaling pathway, Wnt signaling pathway | (43) | |
Hepatocellular carcinoma | circUHRF1 | miRNA sponge, potential biomarker | miR-449c-5p, IFN-γ, TNF-α, TIM-3 | TNF signaling pathway, MAPK signaling pathway | (44) |
Colorectal cancer | circSPARC | miRNA sponge, protein binder, potential biomarker and therapeutic target | miR-485-3p, JAK2, STAT3, FUS | JAK/STAT signaling pathway | (45) |
Infectious diseases | |||||
Pulmonary tuberculosis | hsa_circ_14623 | miRNA sponge, potential biomarker | —— | Endocytosis pathways in cancer, MAPK signaling pathway, HTLV-1 infection, and ubiquitin- mediated proteolysis signaling pathway | (46) |
hsa_circ_09585 | |||||
hsa_circ_005538 | |||||
hsa_circ_09993 | |||||
hsa_circ_00074 | |||||
hsa_circ_13478 | |||||
hsa_circ_0005836 | potential biomarker and therapeutic target | —— | —— | (47) | |
Active tuberculosis | hsa_circ_001937 | potential biomarker | —— | —— | (48) |
Bacterial meningitis | hg38_circ_0002276 | miRNA sponge | hsa-miR-548o-3p | —— | (49) |
hg38_circ_0031043 | hsa-miR-548o-3p | ||||
hg38_circ_ 0027134 | hsa-miR- 148a-3p | ||||
hg38_circ_ 0032477 | hsa-miR- 148a-3p | ||||
hg38_circ_0008980 | hsa-miR-660-5p | ||||
hg38_circ_0001582 | hsa-miR-194-5p | ||||
hg38_circ_0017427 | hsa-miR-107 | ||||
Viral infection | circRNAs | interacting with proteins | K63, RIG-I, IRF3, NF90/110 | Innate immunity | (50, 51) |
COVID-19 | Ppp1r10 | miRNA sponge | mmu-miR-124-3p, Ddx58, Gm26917 | Antiviral mechanism by IFN-stimulated genes | (52) |
C330019G07RiK | |||||
Microbial infection | circRasGEF1B | maintaining the stability of the mature mRNA | ICAM-1, LPS, NF-κB | LPS pathway, NF-κB pathway, cell cycle, macrophage polarization | (53) |
Chlamydia infection | hsa_circ_001226 | miRNA sponge | —— | Endocytosis, MAPK and PI3P-Akt signaling pathway | (54) |
hsa_circ_007046 | |||||
hsa_circ_400027 |